<DOC>
	<DOCNO>NCT00671151</DOCNO>
	<brief_summary>Molecular mechanism COPD exacerbation modulate effect low dose theophylline inflammation elucidate project . NF-kappa B-dependent pathway acetylation status nuclear histone studied.Design : control , prospective randomize study without theophylline , potent HDAC activator.Objectives : 1 ) To determine NF-kB activation , histone deacetylase ( HDAC ) histone acetyl-transferase ( HAT ) activity sputum macrophage blood monocyte episode exacerbation 3 month later , stability achieve . To correlate measurement inflammatory oxidative stress marker pulmonary function clinical variable . 2 ) To assess effect theophylline previous molecular , functional clinical data . Method : 25 patient COPD recruit episode exacerbation require hospitalization . NF-kB activation , HDAC HAT activity , marker inflammation oxidative stress determine specific assay . These determination repeat patient stable compare smoker non smoker control normal lung function</brief_summary>
	<brief_title>Effects Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease ( COPD ) Exacerbations</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Severe COPD accord GOLD guideline Age 40 75 Admission hospital due COPD exacerbation History asthma Pulmonary embolism Pneumonia Other chronic inflammatory disease Patient theophylline time admission Patient oral steroid time admission</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>COPD exacerbation</keyword>
	<keyword>histone</keyword>
	<keyword>steroid resistance</keyword>
	<keyword>inflammation</keyword>
	<keyword>theophylline</keyword>
</DOC>